Megan Isaacson-Schmid
Medical · Saint Louis, MONPI 1124546726
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.0% of the total across 946 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 15.6% — the pattern of someone who eats at a lot of different presentations. Among medical clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 946 payments — averaging $17.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Johnson & Johnson$3K
- Amgen$2K
- UCB, Inc.$2K
- Pfizer$2K
- Novartis$1K
- plus $5K from 29 others
What the payments were for
- Food & beverage$16,32599%
- Education$1721%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 142 | $2,582 |
| Johnson & Johnson | 145 | $2,523 |
| Amgen(2 entities) | 152 | $2,201 |
| UCB, Inc. | 79 | $1,623 |
| Pfizer | 96 | $1,507 |
| Novartis | 92 | $1,487 |
| Lilly USA, LLC | 47 | $814 |
| AstraZeneca(2 entities) | 37 | $708 |
| GSK | 34 | $510 |
| Radius Health, Inc. | 16 | $386 |
| Organon | 15 | $321 |
| Boehringer Ingelheim | 13 | $259 |
| Aurinia Pharma U.S., Inc. | 13 | $240 |
| Sobi, Inc | 7 | $201 |
| Sandoz | 7 | $106 |
| Kiniksa Pharmaceuticals International, PLC | 4 | $93 |
| Grifols USA, LLC | 4 | $91 |
| Mallinckrodt Hospital Products Inc. | 4 | $89 |
| ANI Pharmaceuticals, Inc. | 4 | $80 |
| Sanofi-aventis U.S. LLC | 1 | $70 |
| Kyowa Kirin, Inc. | 4 | $69 |
| Octapharma USA, Inc. | 3 | $66 |
| Kiniksa Pharmaceuticals, Ltd. | 3 | $57 |
| Pacira Therapeutics, Inc. | 4 | $55 |
| Genentech USA, Inc. | 4 | $55 |
| Sanofi | 2 | $55 |
| Tersera Therapeutics LLC | 2 | $49 |
| E.r. Squibb & Sons, L.L.C. | 2 | $42 |
| Ultragenyx Pharmaceutical Inc. | 2 | $37 |
| Merck | 2 | $31 |
| Fresenius Kabi USA, LLC | 2 | $30 |
| Celltrion USA Inc. | 1 | $17 |
| Biogen | 1 | $16 |
| Invivyd Inc | 1 | $14 |
| Cumberland Pharmaceuticals, Inc. | 1 | $13 |
How this compares
$16,497 in reported general payments places this provider in the 95th percentile of 198 medical providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 27 | $338,996 |
| RinvoqUpadacitinib | 12 | $74,189 |
| Actemra ActpenTocilizumab | 11 | $44,760 |
| SavellaMilnacipran Hcl | 24 | $29,110 |
| Leflunomide | 114 | $8,721 |
| Hydroxychloroquine Sulfate | 146 | $6,692 |
| MethotrexateMethotrexate Sodium | 238 | $6,486 |
| Sulfasalazine DrSulfasalazine | 22 | $1,145 |
| Azathioprine | 46 | $1,124 |
| Prednisone | 188 | $1,039 |
| Duloxetine Hcl | 35 | $985 |
| Mycophenolate Mofetil | 15 | $781 |
| Celecoxib | 28 | $736 |
| Folic Acid | 71 | $647 |
| Gabapentin | 51 | $583 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRinvoq, Savella | $2,582 | $103,29936 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 198 medical providers in Missouri.
Other medical in Saint Louis
- Amy MosmanSaint Louis$21K
- Alexa Fider-WhyteSaint Louis$18K
- Erin YoffieSaint Louis$16K
- Beatrice BernhartSaint Louis$15K
- Lindsay ExlineSaint Louis$8K
- Mustafa AhmedSaint Louis$8K
- Elizabeth HowardSaint Louis$4K
- Macara JacobsSaint Louis$4K
- Kayla BergmannSaint Louis$4K
- David VanhoornbeekSaint Louis$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.